Position in TECH
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$875,511
-$182,128 QoQ
Shares Held
16,753
-6.8% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TECH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026HANTZ FINANCIAL SERVICES, INC. holds $27,021,973 across 66 Biotechnology names. TECH ranks #6 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
17,807 | $7,951,537 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
17,673 | $5,847,465 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
61,685 | $3,986,701 | |
| 4 | ARGX |
Argenx SE
|
1,434 | $1,047,178 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
31,870 | $882,799 | |
| 6 | TECH |
BIO-TECHNE Corp
This page
|
16,753 | $875,511 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
11,338 | $640,483 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
3,293 | $622,541 |
All Filings in TECH
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $875,511 | 16,753 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $1,057,639 | 17,984 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $890,691 | 16,011 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $641,787 | 12,474 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $859,691 | 14,663 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,022,537 | 14,196 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $1,115,822 | 13,960 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $940,477 | 13,126 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $920,630 | 13,079 | Shares | Sole | 2024-08-06 | |
| 2023-12-31 | $1,047,292 | 13,573 | Shares | Sole | 2024-08-06 | |
| 2023-09-30 | $967,683 | 14,216 | Shares | Sole | 2024-08-06 | |
| 2023-06-30 | $1,116,045 | 13,672 | Shares | Sole | 2024-08-06 | |
| 2023-03-31 | $994,220 | 13,401 | Shares | Sole | 2024-08-06 | |
| 2022-12-31 | $1,027,877 | 12,402 | Shares | Sole | 2024-08-06 | |
| 2022-09-30 | $782,988 | 2,757 | Shares | Sole | 2024-08-06 | |
| 2022-06-30 | $720,664 | 2,079 | Shares | Sole | 2024-08-06 | |
| 2022-03-31 | $801,557 | 1,851 | Shares | Sole | 2024-08-06 | |
| 2021-12-31 | $824,639 | 1,594 | Shares | Sole | 2024-08-06 | |
| 2021-09-30 | $623,157 | 1,286 | Shares | Sole | 2024-08-06 | |
| 2021-06-30 | $398,480 | 885 | Shares | Sole | 2024-08-06 | |
| 2021-03-31 | $287,593 | 753 | Shares | Sole | 2024-08-06 | |
| 2020-12-31 | $241,973 | 762 | Shares | Sole | 2024-08-06 | |
| 2020-09-30 | $193,724 | 782 | Shares | Sole | 2024-08-06 | |
| 2020-06-30 | $205,974 | 780 | Shares | Sole | 2024-08-06 | |
| 2020-03-31 | $147,903 | 780 | Shares | Sole | 2024-08-06 | |
| No filing history on record for this holder in this stock. | ||||||